semaglutide 0.5mg/0.375ml inj pen 1.5ml Ozempic Injection for Type 2 Diabetes It is used by certain overweight people Semaglutide Injection 5 mg/ml 2.5mg

September 2023: FDA added ileus to Ozempic's warning label

As specified in NICE TA875, patients using Wegovy should receive treatment within specialist weight management services with ongoing healthcare professional support to review weight loss progress, manage side effects, and adjust dietary approaches as needed

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation

doi: 10.1007/s13300-021-01078-y Petri KCC, Ingwersen SH, Flint A, Zacho J, Overgaard RV

Cost and access in the UK Saxenda has been discontinued Novo Nordisk has discontinued production of Saxenda to focus manufacturing capacity on newer medications, such as Wegovy